NMN vs NAD+: What the Research Actually Shows

The NAD+ Problem

Nicotinamide adenine dinucleotide (NAD+) is a coenzyme present in every living cell. It's essential for hundreds of metabolic reactions, including energy production, DNA repair, and sirtuin activation — the protein family most closely linked to longevity in research models.

The problem: NAD+ levels decline with age. By age 50, studies suggest NAD+ levels may be 50% lower than at age 20. This decline is correlated (though not proven causal) with many hallmarks of aging: mitochondrial dysfunction, DNA damage accumulation, and metabolic decline.

The question: Can you restore NAD+ levels by supplementing with either NAD+ directly or its precursor NMN (nicotinamide mononucleotide)?

Quick Comparison

How NAD+ Is Made in the Body

NAD+ can be synthesized through several pathways:

1. Salvage pathway (primary): Nicotinamide → NMN → NAD+ (via the enzyme NAMPT)
2. Preiss-Handler pathway: Nicotinic acid → NAAD → NAD+
3. De novo pathway: Tryptophan → quinolinate → NAD+

NMN is one step upstream of NAD+ in the salvage pathway. NR (nicotinamide riboside, another popular supplement) is two steps upstream.

The Key Question: Direct NAD+ or Its Precursor?

The Case for NMN

• Smaller molecule (334 vs 663 g/mol) — potentially better absorption
• Human clinical data: The METRO trial (2022) showed oral NMN increased blood NAD+ metabolites in a dose-dependent manner
• More human trials: At least 5 published human studies as of 2025
• Specific transporter identified: The SLC12A8 transporter appears to enable direct NMN uptake into cells in animal models
• David Sinclair's research: High-profile advocacy from the Harvard longevity researcher (note: he has financial interests in NMN companies)

The Case for NAD+

• The molecule you actually need: No conversion step required
• Sublingual/IV routes may bypass absorption concerns: Under-the-tongue or intravenous NAD+ delivers the molecule directly
• Some research suggests oral NAD+ does raise tissue levels: Despite skepticism about oral bioavailability, several studies show measurable effects
• Potentially faster onset: If it can be absorbed, no enzymatic conversion needed

The Honest Answer

Neither compound has definitive evidence of slowing aging in humans. The entire field is in the "promising preclinical data + early human pharmacokinetics" stage. We know both can raise measurable NAD+ markers in blood. We don't yet know if that translates to the longevity benefits seen in animal models.

What the Human Trials Show

NMN Human Data

• METRO trial (2022): 250mg/day for 12 weeks raised blood NAD+ metabolites. No clinical outcome data.
• NMN + exercise study (2021): NMN supplementation improved aerobic capacity in amateur runners
• Postmenopausal women (2022): NMN improved insulin sensitivity markers
• Limitation: All trials are small (< 100 participants), short-duration, and measured biomarkers not clinical outcomes

NAD+ Human Data

• IV NAD+: Used clinically for decades in addiction and detox settings. Raises NAD+ levels dramatically but requires IV administration
• Oral NAD+: Limited published data on oral formulations specifically
• Combination products: Some studies combine NAD+ with precursors, making it hard to isolate the NAD+ effect

Price Comparison

NMN is generally more affordable than NAD+ per equivalent dose:

• NMN: $30-80/month for 250-500mg daily
• NAD+ oral: $60-150/month for equivalent
• NAD+ IV: $250-1000 per session

Our Take

For oral supplementation, NMN currently has stronger human trial data and better-established bioavailability. For direct NAD+ delivery, sublingual or IV routes are more promising than oral capsules.

Neither is a proven anti-aging intervention in humans. Both are reasonable research compounds for individuals interested in the NAD+ restoration hypothesis. The field is moving fast — check PubMed regularly for new trial data.

For research purposes only. Not medical advice.